Pharmaceutical Research 2015-02-01

Applicability of a newly developed bioassay for determining bioactivity of anti-inflammatory compounds in release studies--celecoxib and triamcinolone acetonide released from novel PLGA-based microspheres.

Hsiao-yin Yang, Maarten van Dijk, Ruud Licht, Michiel Beekhuizen, Mattie van Rijen, Martina Källrot Janstål, F Cumhur Öner, Wouter J A Dhert, Detlef Schumann, Laura B Creemers

Index: Pharm. Res. 32(2) , 680-90, (2015)

Full Text: HTML

Abstract

To develop a bio-assay for measuring long-term bioactivity of released anti-inflammatory compounds and to test the bioactivity of celecoxib (CXB) and triamcinolone acetonide (TA) released from a new PLGA-based microsphere platform.Human osteoarthritic chondrocytes were plated according to standardized procedures after batch-wise harvest and cultured for 3 days to prevent cell confluency and changes in cell behaviour. Prostaglandin E2 (PGE2) production stimulated by TNFα was used as a parameter of inflammation. A novel microsphere platform based on PTE-functionalised PLGA was used to incorporate CXB and TA. Loaded microspheres were added to transwells overlying the cells, with transfer of the wells to new cell cultures every 3 days. Inhibition of PGE2 production was determined over a period of 21 days.PLGA(75:25)-PTE microspheres were prepared and loaded with CXB and TA at 86 and 97% loading efficiency, respectively. In the bioactivity assay, PGE2 levels induced by TNFα were reduced to an average of 30% using microspheres loaded with 0.1 nmol CXB per transwell; with microspheres loaded with 0.1 nmol TA, PGE2 production was initially reduced to 3% and gradually recovered to 30% reduction. At 1 nmol loading, PGE2 was inhibited to 0-7% for CXB-loaded microspheres, and 0-28% for TA-loaded microspheres.We present a novel sustained release bioactivity assay which provides an essential link between in vitro buffer-based release kinetics and in vivo application. Novel PLGA-based microspheres loaded with TA and CXB showed efficient anti-inflammatory effects over time.

Related Compounds

Structure Name/CAS No. Articles
Sodium azide Structure Sodium azide
CAS:26628-22-8
Methanol Structure Methanol
CAS:67-56-1
sodium dodecyl sulfate Structure sodium dodecyl sulfate
CAS:151-21-3
Dichloromethane Structure Dichloromethane
CAS:75-09-2
thf Structure thf
CAS:109-99-9
Dimethyl sulfoxide Structure Dimethyl sulfoxide
CAS:67-68-5
Dinoprostone Structure Dinoprostone
CAS:363-24-6
Diethylene glycol Structure Diethylene glycol
CAS:111-46-6
1,4-Dioxane-2,5-dione Structure 1,4-Dioxane-2,5-dione
CAS:502-97-6
L-Lactide Structure L-Lactide
CAS:4511-42-6